ECM Weekly (29 Mar 2020) - Wuxi AppTec, Kintor Pharma, Softbank Group-Driven Placements and More!
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. We...
683 Views
Kintor Pharma (å¼ęčÆäø) Pre-IPO: Thoughts on Valuation
Kintor was founded by Chinese academic researchers returning from overseas. It has two main drugs, proxalutamide which targets prostate cancer and...
1k Views
Kintor Pharma (å¼ęčÆäø) Pre-IPO: Interesting Prostate Cancer Drug but Low in Core Assets
Kintor was founded by Chinese academic researchers returning from overseas. It has two main drugs, proxalutamide which targets prostate cancer and...
725 Views